Haemagological Times has this month published a couple of research articles examining ways to improve control of Graft Versus Host Disease (GVHD), the potentially deadly risk associated with bone marrow transplants, where T-Lymphocytes produced from the donor's transplanted bone marrow attack the transplant patient's cells. Both techniques modify the donor T - cells in an extension of CAR-T technology:
Haemagological Times registration is free.
Modified T cells may treat GVHD
Combo can fight infection, GVHD
Photo: Pincushion Hakea